Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Collaborative Human Tissue Network
Action of Novel Retinyl Ethers in Breast Cancer Control
Core - Biomedical Communications Shared Resource
Immunology and Immune Based Therapy Agenda
Immune Response Genes and Systemic Lupus Erythematosus
Recently added grants:
Mechanisms of MHCII expression and CD4+ T cell activation during Chlamydia trachomatis infection
In Vivo Gene Editing for HIV-1 Cure
Molecular mechanisms of the first-identified bacterial HORMA and Pch2-like proteins in a novel second-messenger signaling pathway
Mechanisms of transcriptional regulation of ccr5 and host genetic control of HIV
Epigenomic profiling of neurotrophic herpesvirus chromatin by controlled antibody-targeted cleavage.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67186-2-0-1
Application #
7574878
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hospital & Res Ctr at Oakland
$366,202
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Morris, Claudia /
$359,807
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant
